Bgm (BGM) Debt Ratio (2019 - 2025)

Bgm (BGM) posted quarterly Debt Ratio of 0.0 for Q3 2025, down 51.7% quarter-over-quarter from 0.01 in Q1 2025.

Bgm (BGM) Debt Ratio (2019 - 2025) Analysis & Trends

Bgm (BGM) has reported Debt Ratio for 5 consecutive years, with 0.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Sep 2025 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.0, changed N/A from the prior year.
Debt Ratio eased to 0.0 in Q3 2025 per BGM's latest filing, from 0.01 in the prior quarter.
Across five years, Debt Ratio topped out at 39340383870.41 in Q1 2022 and bottomed at 0.0 in Q3 2022.
Historically, Debt Ratio has averaged 7868076774.09 across 3 years, with a median of 0.01 in 2025.
On a YoY basis, Debt Ratio climbed as much as 329.58% in 2023 and fell as far as 329.58% in 2023.
Bgm's Debt Ratio stood at 0.0 in 2022, then surged by 329.58% to 0.01 in 2023, then plunged by 60.14% to 0.0 in 2025.
Business Quant data shows BGM's Debt Ratio at 0.0 in Q3 2025, 0.01 in Q1 2025, and 0.01 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-0.13
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	0.42
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	0.60
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	0.32
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.38
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	0.29
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	0.12
10	Bgm	30.61 Mn	20.79 Mn	-	0.00

Download Data